Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Catalyst Health Ventures (CHV) is a Boston-based venture capital firm founded with the mission to invest in transformative medical technology (MedTech) solutions that address significant unmet healthcare needs globally. Established to support innovative healthcare solutions, CHV collaborates closely with entrepreneurs, providing essential resources, mentorship, and connections to navigate the complexities of the healthcare landscape. The firm primarily focuses on early-stage investments, targeting companies at the seed through Series B funding stages. With a strong emphasis on capital efficiency, CHV seeks to back businesses that demonstrate robust technological foundations, clear regulatory pathways, and scalable business models.
CHV has built a reputation for its strategic approach to investing in the healthcare sector, particularly in North America. The firm’s leadership comprises seasoned professionals with extensive experience in healthcare and venture capital, enabling them to identify and nurture promising startups. With a commitment to fostering innovation, CHV has successfully raised multiple funds, although specific fund sizes and assets under management (AUM) are not disclosed. The firm’s collaborative approach and deep industry connections position it as a valuable partner for entrepreneurs looking to make a significant impact in the MedTech space.
CHV specializes in investing in early-stage companies that are developing breakthrough medical technologies. This includes a wide range of sectors such as therapeutic devices, digital health solutions, and diagnostic devices. The firm typically engages with startups at the seed through Series B stages, particularly during critical transitions from pre-clinical to clinical development. CHV is particularly interested in companies that demonstrate capital efficiency, which indicates a prudent use of resources to achieve growth and development.
In addition to capital efficiency, CHV looks for strong technological foundations in the companies it invests in. This means that the startups should have a solid technological base that can support their innovations and ensure their viability in the competitive healthcare market. Clear regulatory pathways are also a crucial factor in CHV's investment decisions, as navigating regulatory challenges is often a significant hurdle for healthcare startups. Furthermore, the firm seeks scalable business models, ensuring that the companies it backs have the potential for significant growth and impact in the healthcare sector.
CHV's portfolio is impressive, featuring notable companies that have made significant strides in the MedTech sector. Among its investments are Veracyte, Inc. (NASDAQ: VCYT), Boston Scientific (NYSE: BSX), Agilent Technologies (NYSE: A), Life Technologies (NYSE: TMO), Medline Systems, and AngioDynamics (NASDAQ: ANGO). These companies have not only demonstrated innovation in their respective fields but have also been acquired by leading firms, showcasing the potential and value of CHV's investment strategy.
The firm’s focus on high-value medical devices and transformative healthcare solutions has positioned it as a key player in the MedTech investment landscape. By backing companies that are at the forefront of medical technology innovation, CHV contributes to advancements that can significantly impact patient care and healthcare delivery.
To pitch Catalyst Health Ventures, founders should visit their website at chv.vc or email info@chv.vc. They prefer pitches that include detailed information about the startup's technology, market potential, and business model. Warm introductions are encouraged, but cold applications are also accepted.
Recently, Catalyst Health Ventures has been active in promoting its portfolio and team developments. Notable updates include the commercial launch of Instylla's Embrace™ Hydrogel Embolic System, the promotion of David Mackey to Partner, and a collaboration announcement between Abbott and AtaCor Medical on advanced ICD technology. These activities highlight CHV's ongoing engagement with industry advancements and internal growth.
Catalyst Health Ventures invests in early-stage companies, specifically at the seed, Series A, and Series B stages. This focus allows them to support startups during critical phases of development, particularly as they transition from pre-clinical to clinical stages.
Founders can pitch Catalyst Health Ventures by visiting their website at chv.vc or by emailing them directly at info@chv.vc. They welcome pitches that clearly outline the business model, technological foundation, and regulatory pathways of the startup.
CHV primarily focuses on the healthcare sector, with a particular emphasis on medical technology (MedTech). This includes investments in therapeutic devices, digital health solutions, and diagnostic devices that address unmet healthcare needs.
While specific check sizes are not disclosed, CHV typically invests in early-stage companies, which suggests that their investments are aligned with the funding needs of seed to Series B stage startups.
CHV primarily invests in North America, focusing on startups that are developing innovative healthcare solutions within this region.
The application process involves submitting a pitch through their website or via email. Founders should ensure that their pitches include detailed information about their technology, market potential, and business model.
CHV collaborates closely with its portfolio companies, offering mentorship, resources, and connections to help navigate the complexities of the healthcare landscape. This support is crucial for startups aiming to scale their innovations effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.